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Abstract
Berberine (BBR) is an established natural DNA intercalator with numerous pharmacological functions. However, currently
there are neither detailed reports concerning the distribution of this alkaloid in living cells nor reports concerning the
relationship between BBR’s association with DNA and the function of DNA. Here we report that the distribution of BBR
within the nucleus can be observed 30 minutes after drug administration, and that the content of berberine in the nucleus
peaks at around 4 mmol, which is twelve hours after drug administration. The spatial conformation of DNA and chromatin
was altered immediately after their association with BBR. Moreover, this association can effectively suppress the
transcription of DNA in living cell systems and cell-free systems. Electrophoretic mobility shift assays (EMSA) demonstrated
further that BBR can inhibit the association between the TATA binding protein (TBP) and the TATA box in the promoter, and
this finding was also attained in living cells by chromatin immunoprecipitation (ChIP). Based on results from this study, we
hypothesize that berberine can suppress the transcription of DNA in living cell systems, especially suppressing the
association between TBP and the TATA box by binding with DNA and, thus, inhibiting TATA box-dependent gene
expression in a non-specific way. This novel study has significantly expanded the sphere of knowledge concerning
berberine’s pharmacological effects, beginning at its paramount initial interaction with the TATA box.
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Introduction
Berberine (BBR) is a natural quaternary ammonium salt from
the group of isoquinoline alkaloids. Modern pharmacological
research have discovered that BBR is a multi-pharmacological
molecule exhibiting anti-inflammatory [1], cell cycle inhibition [2],
anti-diabetic [3] and neuroprotective properties [4]. According to
several medical studies, BBR has activities against and has already
been used to treat dysentery, hypertension, inflammation, and
liver disease in clinics [5,6].
Since the 1960s, many researchers have been interested in the
interaction between BBR and cell nuclei [7-10]. These previous
studies have established that BBR belongs to a class of alkaloid
DNA intercalators and is cell-permeable so that it can be
transported into the cell via a cation transporter and expelled by
P-glycoprotein [11,12]. However, no prior study has revealed to us
the complete account describing what occurs once BBR has been
transported into a living cell. What is the relationship between
BBR’s DNA intercalating character and its broad range of
activities?
In this research, a complex and dynamic process of BBR
entering from a medium into a living cell nucleus was described for
the first time. The transcriptional levels of the global genome and
several artificial plasmids, including TATA box-dependent and
TATA box-independent genes, were compared before and after
BBR addition. Coupled with data from a cell-free transcription
system, the disruptive effect observed via EMSA and ChIP of BBR
binding to the TATA box on the association between TBP and the
TATA box allows us to hypothesize that BBR can suppress the
transcriptional ability of genes in a non-specific way when it
distributes throughout a living cell nucleus. One of the underlying
mechanisms is the stereospecific blockade and the spatial
conformational change in DNA and chromatin caused by the
association between BBR and DNA, which blocks TBP from
binding to the TATA box, ultimately suppressing the initiation of
gene transcription. The TATA box is, therefore, one of BBR’s
crucial targets for suppression of DNA transcription in living cells.
Materials and Methods
Preparation of Chromatin & Genomic DNA from Rat Liver
Male albino Sprague-Dawley rats weighing around 220610 g
and about 2 months old in age were used throughout this study.
Nuclei were isolated from the homogenized liver by using a
method described previously by Blobel and Potter [13]. The
quality of the collected nuclei was tested according to the protocol
described by Bonner [14]. Genomic DNA was obtained from the
homogenized liver by using a TIANamp Genomic DNA Kit
(Tiangen Biotech, China). All the biological experiments were
conducted under the supervision and approval of Institutional
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Animal Welfare & Ethics Committee of Tsinghua University
(Approval ID: 2010-DuLJ-Neuron).
Cytotoxicity assay
The PC12 cells (obtained from the tumor cells library of
Chinese Academy of Medical Sciences commercially) used in this
study derive from a cell line from a pheochromocytoma of the rat
adrenal medulla. The cytotoxicity of BBR in PC12 cells was
evaluated by an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide) assay and a Lactate dehydrogenase (LDH)
cytotoxicity assay. The MTT assay was performed according to
the method described by Mosmann [15] and the LDH cytotoxicity
assay was performed according to the manufacturer’s guidelines
(CytoTox 96 Non-Radioactive Cytotoxicity Assay, Promega,
USA).
Plasmid Transfection
Plasmids driven by the TPH2 promoter and IgG promoter were
constructed previously [16,17] and stored at the Laboratory of
Pharmaceutical Sciences at Tsinghua University. Plasmids driven
by the PPARcpromoter were kindly provided by Dr. Fan Lei.
pEGFP-N1 and pDsRed-Express-N1 were kindly provided by
Professor. Yeguang Chen. pEGFP-N1-hTBP was constructed by
fusing the human TATA binding protein with green fluorescent
protein. Plasmids were transfected into PC12 cells by a Lipofect
Transfection Reagent (Tiangen Biotech, China) according to the
manufacturer’s guidelines.
Quantitative analysis of RNA
The total RNA from PC12 cells was extracted using RNAprep
pure Cell/Bacteria Kit (Tiangen Biotech, China). The total
content of RNA was measured by using a GeneQuant 100
Spectrophotometer (General Electric Company, Germany).
Real-Time polymerase chain reaction
Real-Time PCR was conducted using a RealMasterMix (SYBR
Green) Kit (Tiangen Biotech, China). Primers for detecting GFP
were: forward 59-GCAGAAGAACGGCATCAAGG-39 and re-
verse 59- CGGACTGGGTGCTCAGGTAG-39; primers for
detecting RFP were: forward 59- AGAAGAAGACTATGGG-
CTGG-39 and reverse 59- CGTTGTGGGAGGTGATGT-39;
primers for detecting the TATA box-containing sequence from the
CMV promoter were: forward 59- CTCACGGGGATTTCC-
AAGTC -39 and reverse 59- CTGACGGTTCACTAAACCA-
GCT -39. Signals from SYBR Green were recorded and analyzed
by the CFX96 Real-Time PCR System (Bio-Rad, USA).
Absorbance and Fluorescence Measurement
The analysis of the interaction between BBR and testing
components (plasmid DNA, genomic DNA, and chromatin) was
performed via fluorometric titration on a RF-5301PC Spectroflu-
orometer (Shimadzu, Japan). A 3.0 mL solution, containing
10 mmol of BBR in 10 mmol of Tris-HCl (pH 8.0), was titrated
by successive additions of solution composed of testing compo-
nents. Titrations were done manually by adding the corresponding
storage solution. The fluorescence emission spectra was recorded
at a temperature of 20uC in the wavelength range of 400–650 nm
and with an exciting wavelength of 456 nm. To test the interaction
of BBR with proteins that comprise the chromatin, 3.1 mmol of
chromatin were titrated with discontinuous additions of BBR
solution. The fluorescence emission spectra were recorded in the
wavelength range of 280–400 nm with the exciting wavelength at
280 nm. All other experimental conditions were identical to those
stated above. Appropriate blanks corresponding to the buffer
solution were subtracted to correct for background fluorescence.
Confocal microscopy
PC12 cells were used in the experiment when they reached 70%
confluence. BBR-treated (2.69 mmol) cells were then fixed.
Nucleus staining of fixed cells was done with propidium iodide
(PI) and acridine orange (AO). For recording the dynamic process
of BBR entering the nucleus of living cells, the ‘‘stack’’ and ‘‘time
series’’ modes was used with a time interval of 1.2 min, and
neither fixation nor nucleus staining proceeded. Images were taken
with a Zeiss LSM 710 Confocal Microscope (Carl Zeiss, Germany)
and analyzed by Zen Light Edition Software.
Isothermal Titration Calorimetry
Isothermal calorimetric measurements were performed in a
NANO-ITC 5300 (TA Instruments, USA) at 20uC, equipped with
a temperature controller. Titration of BBR against different testing
components was performed by injecting BBR (1000 mmol) into the
testing components. Twenty-five titrations were performed with a
volume of 10 mL each time. A blank experiment in which BBR
was injected into buffer (10 mmol Tris-HCl, pH 8.0) with no
testing component was performed to correct for dilution in the
data. The background was subtracted from the measured heat
data and the corrected heat data were plotted against the molar
ratio as well as analyzed using the manufacturer’s software,
yielding the stoichiometry n (number of berberine molecules/
number of base pairs), the equilibrium dissociation constant
(Kd=1/Ka), and the enthalpy (DH).
Dynamic Light Scattering
Dynamic light scattering experiments were performed using a
DynaPro Dynamic Light Scattering Instrument (Wyatt Technol-
ogy Corporation, USA), equipped with a laser of wavelength
832.6 nm. The size of the particles was calculated using the
manufacturer’s software.
Circular Dichroic Spectroscopy
Circular dichroic (CD) measurements were made in a JASCO J-
500 Spectropolarimeter (Jasco Corporation, Japan) at 20uC,
equipped with a temperature controller. The CD scans were
recorded within the wavelength range of 220–350 nm, at a
sensitivity set to 10 mdeg, with a scan speed of 20 nm per minute,
and with a step size of 0.5 nm. The time constant was 1 s and
bandwidth was 0.2 nm. All measurements were made in a cuvette
of 1 mm path length in a reaction volume of 200 mL in 10 mmol
Tris-HCl (pH 8.0) at 20uC. All spectra depict the average of three
runs. They were smoothed within permissible limits by the
instrument’s built-in software.
Analysis of GFP expression by flow cytometry
A BD Calibur Flow Cytometer system (BD Inc, USA) was used
to analyze the expression of GFP.
Quantitative analysis of berberine in a living cell by high
performance liquid chromatography (HPLC)
The HPLC system and procedure used for quantitative analysis
of the BBR content in living cells were identical to those described
in previous literature [18]. The concentration of BBR in a living
cell was calculated by using the following equation: C~
T
N|V
,
where C is the concentration of BBR in a living cell, T is the total
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cells detected by the hematocyte counter, and V is the volume of a
living cell, which was assumed to be 1.5610
212/L [19]. The
concentration of BBR in the nucleus was computed according to
the following equation: Cn~
Fn
FnzFc
, where Cn is the concentra-
tion of BBR in the nucleus, Fn is the fluorescent intensity of BBR
in the nucleus, and Fc is the fluorescent intensity of BBR in the
cytoplasm.
Transcription analysis in a cell-free system
The effect of BBR on the transcription of DNA was investigated
using the HelaScribe Nuclear Extract in vitro Transcription
System (Promega, USA). The protocol used in this experiment was
modified according to the manufacturer’s guidelines: the positive
control DNA was used as a template in all groups and the volume
used was 2 mL; RNA product was washed twice with 70% ethanol
to flush the radioactive rGTP which is not incorporated in the
transcription product; the content of RNA product was measured
using a MicroBeta Jet-Microplate Scintillation and Luminescence
Counter (PerkinElmer, USA).
Electrophoretic mobility shift assay
Forty-eight hours after the plasmid pEGFP-N1-hTBP trans-
fected into PC12 cells, nuclear extracts were prepared by using a
NE-PER Nuclear and Cytoplasmic Extraction Reagent Kit
(Pierce, USA) according to the manufacturer’s guidelines. The
TATA box-containing oligonucleotide was synthesized as com-
plementary oligodeoxyribonucleotide strands and labeled by a
Biotin 39 End Labeling Kit (Thermo, USA). The TATA box
sequence has been described previously [20]: 59-GAAGGGG-
GGCTATAAAAGGGGGTG-39.
The association between the TATA binding protein (TBP) and
the TATA box was assessed using the LightShift Chemilumines-
cent EMSA Kit (Pierce, USA). The labeled TATA box probe was
incubated with different dosages of BBR just before the binding
reaction. The binding reaction and gel detection were performed
according to the manufacturer’s guidelines.
Chromatin immunoprecipitation and Western blotting
Forty-eight hours after the plasmid pEGFP-N1-hTBP trans-
fected into PC12 cells, the cells were grouped and sampled. The
content of TATA box-containing sequences in the CMV promoter
that were associated with TBP was detected using an EZ-ChIP
Chromatin Immunoprecipitation Kit (Millipore, US) according to
the manufacturer’s guidelines. The protocol for Western blotting
was identical to one described previously [21]. The antibody used
in ChIP and Western blotting was ChIP grade (ab51841) from
Abcam (Abcam, USA).
Statistical analysis
All values were expressed as mean 6 S.D. Data were statistically
analyzed using one-way ANOVA followed by Dunnet’s test.
P,0.05 was accepted as statistical significance.
Results
Berberine can enter the cell nucleus within 30 minutes in
a dynamic process
To determine whether BBR could enter cells, we observed the
distribution of BBR in living cells by a confocal assay. A safe dose
of berberine (2.69 mmol) was used throughout the entire study
based on the results of a cytotoxicity assay (Fig. 1 A (I) & A (II); B
(I) & B (II)). The confocal microscope depicted detailed images
regarding BBR distribution in living cells (Fig. 2 A (I)). Continuous
observation revealed that BBR can enter the nucleus in a dynamic
process within 30 minutes after drug administration (Fig. 2 B and
C) and the highest peak of BBR content in the nucleus, at around
4 mmol, was observed by an HPLC assay approximately 12 hours
after the drug was added into the culture medium (Fig. 2 D).
Figure 1. Cytotoxicity assay of berberine. (A) represents the cytotoxicity of BBR from the MTT assay: A(I) and A(II) represent the cytotoxicity of
BBR to PC12 cells 12 hours and 24 hours after drug administration, respectively; (B) represents the LDH release of PC12 cells after BBR addition: B(I)
and B(II) represent the amount of LDH released from PC12 cells 12 hours and 24 hours since BBR incubation. In the MTT assay, the group with 0 mmol
of BBR was considered the control group; in LDH release assay, the spontaneous release of LDH from the BBR-free group (0 mmol) was considered the
control group. The percentage of LDH release was calculated by the equation: LDH release (%)=(Experimental LDH release-Spontaneous LDH
release)/Maximum LDH release. * p,0.05, ** p,0.01 vs control. Data were presented as mean 6 S.D. from twelve independent experiments. (n=12).
doi:10.1371/journal.pone.0023495.g001
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entering the nucleus
The nucleus is the domain that embodies genetic components
and is the prime location where these components exert their
functions. Although previous research have investigated the
interaction of BBR (Fig. 2 E), a DNA intercalator, with nuclei
and artificial DNA models [9,10,22], no data systematically
describing the interaction of BBR with native genetic components
directly extracted from living cells have been made available
despite vast interest in this subject. This association of BBR with
testing components was first probed by fluorescence spectroscopy.
An increase in quantum yield in the fluorescence spectrum of BBR
is the preliminary evidence for the binding of BBR to different
testing components (Fig. 3 A, B and C), which is in accordance
with a previous report concerning the association of BBR with
artificial DNA models [23]. Furthermore, the fluorescence
quenching of tryptophan indicated that BBR not only interacts
with the DNA in chromatin but also associates with the proteins
contained in chromatin (Fig. 3 D).
For additional detailed information regarding the association
between BBR and testing components, isothermal calorimetric
titrations were performed to determine the binding parameters
and associated energetics. Association constants and binding
stoichiometry values between BBR and testing components
obtained from ITC measurements are shown in figure 3 E. From
the binding stoichiometry, the number of base pairs associated with
one BBR molecule (including the genome and plasmids) was almost
100-fold greater than in chromatin, which is in accordance with the
number of base pairs (146 bp) packed into one nucleosome,
suggesting that BBR could associate with DNA and proteins in
chromatin simultaneously but with different affinities. Moreover,
the packaging arrangement of nucleosomes in chromatin would
affect BBR’s accessibility to the portion of DNA packaged in the
interior of the nucleosome.
Berberine can induce spatial conformational changes in
chromatin and DNA
Accordingto theCD spectroscopyofBBRinteractingwithnative
chromatin, genome, and plasmid DNA, BBR influenced the CD
spectra of DNA (genomic DNA and plasmids) in a dose-dependent
manner (Fig. 4 A) and the process of this modification was
completed in one minute (Fig. 4 B). However, no alterations were
observed in the CD spectra of chromatin after BBR administration.
Dynamic light scattering measurements were carried out to further
characterize the ultra-structural consequences of BBR’s association
with chromatin, genome, and plasmid DNA. There was no sig-
nificant change in the mean hydrodynamic diameter of genomic
DNA and plasmid DNA in the presence of BBR (Fig. 4 C).
However, an aggregation of chromatin was observed, suggesting
that the intercalation of this alkaloid into DNA’s minor groove [22]
Figure 2. Distribution of berberine in a living cell. (A) (from I to V) depicts images of the subcellular location of BBR in PC12 cells one hour after
BBR administration. The fluorescence of BBR is shown in blue in A (I); A (II) represents PC12 cells in visible light; A (III) and A (IV) represents the nucleus
stained by PI and AO, respectively; figure A (V) is the merged image of A (I), A (II), A (III), and A (IV). (B) represents the process of BBR entering the
nucleus. The fluorescence of BBR is shown in green in this figure, and the red arrow points to the nuclear region. All of the images in (B) were taken
under the same conditions with a time interval of 1.2 min. (C) represents the fluorescence intensity of BBR in the nucleus. * p,0.05, ** p,0.01 vs
control (0 minutes after BBR administration). (D) represents the time-resolution change of berberine in live cells and the nucleus, which was detected
by HPLC. (E) represents the chemical structure of BBR. Data were presented as mean 6 S.D. from three independent experiments (n=3).
doi:10.1371/journal.pone.0023495.g002
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interaction between BBR and proteins associated with chromatin
could directly induce the alteration in the chromatin’s diameter.
Berberine can inhibit plasmid expression in cells
Given that berberine can induce spatial conformational changes
in DNA (genome and plasmids) by direct association as well as
induce the diameter aggregation of chromatin by its association
with proteins in chromatin, what ramifications would result from
these associations?
Storing and expressing genetic information are fundamental
functions of DNA in the nucleus. In order to explore the
consequences of the spatial conformational alterations in DNA
induced by BBR, plasmids were incubated with BBR during
plasmid transfection. By employing flow cytometry, data from
different groups revealed that BBR could effectively suppress the
expression of the plasmid in living cells at both 12 hours and
24 hours after plasmid transfection, irrelevant of the method of
drug administration (Fig. 5 A, B and C). This suppressive effect
can be eliminated when BBR-treatment is removed (Fig. 5 D).
Berberine can suppress DNA transcription in a living cell
system
According to the central dogma, transcription of DNA is the
first step of protein-encoding gene expression, followed by the
translation of mature mRNA into protein. In order to obtain
more detailed information regarding the effect of BBR on gene
expression, the content of RNA in BBR-treated groups was
compared to that in the non-BBR-treated group. Quantitative
results of their corresponding global RNA levels revealed that BBR
could significantly suppress gene transcription on a global scale
(Fig. 6 A) and that this inhibitory effect could be reversed with the
elimination of BBR (Fig. 6 B).
Two coupled yet distinct dynamic processes determine the RNA
content in living cells: RNA synthesis and RNA degradation. In
order to clearly decipher whether the decreased content of RNA in
the BBR-treated groups was due to an inhibition of RNA synthesis
or due to an accelerated degradation induced by BBR, the half-life
of RNA in living cells was examined after transcriptional
inhibition. Data from this experiment indicated that BBR could
effectively protect the mRNA of plasmid DNA from degradation
Figure 3. Interaction between berberine and genetic components. (A) represents the fluorescence spectrum of BBR (10 mmol) associating
with chromatin (15.3 mmol, spectrum 3; 30.6 mmol, spectrum 2; 45.9 mmol, spectrum 1; 0 mmol, spectrum 4); (B) represents the fluorescence spectrum
of BBR (10 mmol) associating with plasmid (138.2 mmol, spectrum 1; 92.1 mmol, spectrum 2; 44.6 mmol, spectrum 3; 0 mmol, spectrum 4; spectrum 5
and spectrum 6 represent the fluorescent spectrum of plasmid and buffer, respectively); (C) represents the fluorescence spectrum of BBR (10 mmol)
associating with genome (30.8 mmol, spectrum 3; 61.6 mmol, spectrum 2; 92.4 mmol, spectrum 1; 0 mmol, spectrum 4; spectrum 5 represents the
fluorescence spectrum of buffer); (D) represents the fluorescence spectrum of tryptophan in chromatin (3.1 mmol) associating with BBR (0 mmol,
spectrum 1; 10 mmol, spectrum 2; 20 mmol, spectrum 3; 30 mmol, spectrum 4; spectrum 5 and spectrum 6 represent the fluorescence spectrum of BBR
and buffer, respectively). According to (A), (B), and (C), the exciting wavelength is 456 nm and the emission wavelength is 548 nm. The exciting and
emission wavelength in (D) is 280 nm and 330 nm, respectively. (E) portrays the isothermal calorimetric measurements revealing the detailed
parameters concerning the association of BBR with genomic DNA, chromatin, and plasmid DNA, respectively.
doi:10.1371/journal.pone.0023495.g003
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observed on a global scale (Fig. 6 D) where the content of global
RNA in the BBR-treated groups was higher than the global RNA
level in the control group two hours after transcription inhibition.
Therefore, it is confirmed that BBR does indeed decrease the
content of RNA by suppressing gene transcription.
To further validate the suppressive effect of BBR on gene
transcription, the transcription products from five eukaryotic
expression plasmids (Fig. 7 A (I) and 7 (II)) were evaluated by real-
time PCR (Fig. 7 B, C, D, E, F & G), results from which was in
accordance with the data presented in figure 6 A, suggesting that
the suppressive effect of BBR on gene transcription might be gene-
nonspecific.
Berberine can inhibit the transcription of DNA in a cell-
free system
A living cell is a complex system composed of numerous known
and unknown bioactive components. To reject the possibility that
components in the cytoplasm facilitate the process of BBR
suppressing gene transcription, a cell-free transcription system
was used. In accordance with results stated previously in the living
cell system, a dose-dependent suppression of DNA-template
transcription was observed (Fig. 8 A): BBR can significantly
inhibit the transcription of the DNA template with dosages of
2.69 mmol and 26.9 mmol, even when devoid of a cytoplasm as in
a Hela cell.
Berberine can inhibit TATA binding protein from binding
to the TATA box
To validate the suppressive effect on gene transcription and to
determine BBR’s target site during interaction with DNA, EMSA
was employed by using oligonucleotides containing the TATA box
core sequence as a probe. Results from this study demonstrated
that BBR’s association with the TATA box-containing oligonu-
cleotides could dramatically reduce the binding affinity of TATA
binding protein (TBP) to the TATA box at a dosage of 0.269 mmol
(Fig. 8 B (I)), and the IC50 value was 0.3985 mmol (Fig. 8 B (II)).
Furthermore, the suppressive effect of BBR on TBP binding to the
TATA box of the CMV promoter, without fluctuation in TBP
content (Fig. 8 C (I) & C (II)), was also observed in living cells 6
hours after addition of BBR (2.69 mmol) to the growth medium by
means of a ChIP assay (Fig. 8 C (III) & C (IV)), indicating that the
association with DNA is the central reason for the suppression of
gene transcription observed in this entire study.
Discussion
Previous literature coupled with cytotoxicity data obtained from
our laboratory have revealed that at a concentration of 2.69 mmol,
BBR is within a safe dosage range for PC12 cells and is also the
minimum effective dosage for protecting cultured neuron-like
PC12 cells from damage after oxygen and glucose deprivation [4].
In order to investigate the effects of BBR on DNA transcription
Figure 4. Spatial conformational change induced by berberine. (A) represents the dose-dependent alterations in circular dichroic spectrum
of genome, chromatin, and plasmid, respectively. (B) represents the time-dependent alterations in circular dichroic spectrum of genome, chromatin,
and plasmid, respectively. (C) represents the effect of BBR (500 mmol) on the intensity distribution (%) of chromatin (92.4 mmol), genome
(423.2 mmol), and plasmid (808 mmol) in size (diameter) obtained from DLS measurements, respectively.
doi:10.1371/journal.pone.0023495.g004
Berberine Inhibits Gene Transcription
PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e23495with more relevance to its numerous reported pharmacological
functions, the dosage of 2.69 mmol was used according to previous
experiments in living cells.
According to the images obtained from the confocal micro-
scope, the absorption of BBR by PC12 cells from the medium is a
very rapid process, which can be observed 30 minutes after drug
administration by measuring BBR’s fluorescence intensity in the
nucleus. This is the first direct observation that BBR can enter a
living cell and distribute throughout the cytoplasm as well as the
nucleus. This evidence for BBR’s existence within the cell provides
solid support for our hypothesis that BBR’s suppressive effect of
gene transcription is based on its association with DNA. This result
was the basis for our choice of 30 minutes as the first time-point to
study the effect of BBR on gene expression. The curve repre-
senting the time-dependent concentration of berberine in PC12
cells was similar to the one reported by our lab previously in
primary cultured cerebral neurons [11].
Quantitative analysis of the global RNA levels in different trials
revealed that BBR can effectively suppress the transcription level
in living cells on a global scale within 30 minutes after BBR-
treatment, which is in accordance with the time needed for BBR to
enter the nucleus. Coupled with the discovery in this study that
BBR can swiftly alter the spatial conformation of testing com-
ponents (chromatin, plasmids, genomic DNA) after associating
Figure 5. Suppressive effect of BBR on the expression of green fluorescent protein in PC12 cells. (A) and (B) represent the suppressive
effect of BBR on the expression of GFP 12 hours and 24 hours after drug administration, respectively. The value on the x-axis represents the method
of drug administration: (1) denotes that BBR has been incubated with PC12 for 1 hour before transfection; (2) denotes that BBR has been incubated
with plasmid for 5 minutes before transfection; (3) denotes that BBR was administered 6 hours after transfection; (4) denotes transfection without
BBR administration. (C) portrays the method of data collection according to the flow cytometry experiments. C (I), C (II), C (III), and C (IV) represent the
method of data collection of PC12 cells without GFP expression, GFP expressing PC12 cells with BBR treatment for 12 hours, GFP expressing PC12
cells with BBR treatment for 24 hours, and GFP expressing PC12 cells without BBR treatment, respectively. The R2 region in the images in (C)
characterizes the definition of GFP expressing cells in the cell population. (D) depicts the recovery of GFP expression after the elimination of 12 hour-
BBR-treatment (n=3). (Compared with group 4, * p,0.05, ** p,0.01). Fluorescence intensity= G6M, where G indicates the number of fluorescent
cells and M is the mean fluorescence intensity of fluorescent cells.
doi:10.1371/journal.pone.0023495.g005
Berberine Inhibits Gene Transcription
PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e23495with them, the inhibitory effect of BBR on DNA transcription was
inferred, and the interaction between BBR and DNA is considered
the direct cause for this suppressive activity of BBR.
To acquire a more thorough understanding regarding the effect
of BBR on gene transcription, five different promoter-driven
expression plasmids (Fig. 7 A (I) & A (II)) were used as models for
the following purposes: two different fluorescent protein expressing
plasmids (CMV-GFP and CMV-RFP) driven by the CMV pro-
moter (TATA box-dependent) were used to reject the possibility
that BBR has coding sequence specificity; an IgG promoter
(TATA box-independent) and a PPARc promoter (TATA box-
dependent) driving green fluorescent protein expressing plasmids
were used to reject the possibility that BBR has promoter sequence
specificity; and a TPH2 promoter (TATA box-dependent) driving
red fluorescent protein expressing plasmid was used to add a
random sample to support our conclusion. Considering the poten-
tial suppressive effect of BBR on gene transcription, the mRNA
levels of a target gene were presented as the ratio of the target gene
in the BBR group to the same target gene in the BBR-free group
at the same time-point. According to this relative quantitative
analysis, the result of BBR suppressing the transcription of all five
plasmids suggests the conclusion that BBR exhibits a sup-
pressive effect on gene transcription in a non-specific fashion.
However, an interesting question was also raised at the same time:
Despite the time-point at 1 hour after drug administration, we
may inquire why BBR’s suppressive effect on transcription was not
universally observed in all plasmids at subsequent time-points,
which differs from the observed suppressive effect of BBR on
global RNA synthesis? This phenomenon revealed to us that BBR
could effectively suppress the expression of gene in a short-term
fashion but this level of activity varies in the long-term. This
variable effect of BBR on different promoters after long-term
incubation is related to the intricate and complex interactions
between many other regulatory mechanisms that may counter the
suppressive effect of BBR by up-regulating gene expression, such
as the protective effect of BBR on mRNA from degradation,
causing the suppressive effect to be neutralized to different
intensities by such a counteracting mechanism. We believe that
the variances in the long-term effect of BBR on these candidate
promoters represent the adaptability and responses of a living
system to an extraneous stimulus. Although an unresolved pro-
blem remains to be settled here, the non-specific suppressive effect
of BBR on gene transcription, whether containing the TATA box
sequence or not, can still be confirmed.
With the elimination of BBR-treatment, the suppressive effect of
BBR on gene transcription was removed in a time-dependent
fashion (Fig. 6 A (II)), and the slopes indicating the increase in
RNA level between the BBR group and control group were similar
to each other. A cytometric analysis also demonstrated that the
suppressive effect of BBR on gene transcription is reversible (Fig. 5
C), suggesting that the inhibitory effect of BBR on gene expression
is due to the suppression of transcription, rather than the complete
eradication of transcriptional ability. There are two possible
explanations for the cessation of the suppressive effect on gene
transcription after the removal of BBR-treatment: 1) the export of
BBR out of cells by P-glycoprotein [12], and 2) the weak, non-
covalent interactions between BBR and double-stranded DNA
reported previously [24].
The in vitro transcription system used in this study is the nuclear
extract of a Hela cell without cytoplasm. The DNA template used
in this experiment is an artificial gene driven by a CMV promoter,
which contained the TATA box sequence and was identical to the
promoter driving GFP and RFP expression in living cells.
Although the involvement of cytoplasmic factors alongside BBR
Figure 6. The suppressive effect of berberine on gene transcription in live cells. (A) portrays the time-dependent effect of BBR on gene
transcription on a global level. (B) shows the time-dependent recovery of the global RNA level after the elimination of a 12 hour-BBR treatment. The
linear equation of the control group in (B) is: y=4.98366+21.516,R
2=0.8162; the linear equation of the BBR group in (B)is: y=6.62196+15.472,
R
2=0.8941. (C) displays the protective effect of BBR on the global RNA level. (D) depicts the protective effect of BBR on the mRNA level of the
transfected artificial plasmid, pEGFP-N1. The dosage of BBR in all of the experiments was 2.69 mmol. Data in D was the ratio of target gene in the BBR
group to the same target gene in the BBR-free group at the same time-point (control group). * p,0.05, ** p,0.01 vs the corresponding control
indicated above. Data were presented as mean 6 S.D. from four independent experiments (n=4).
doi:10.1371/journal.pone.0023495.g006
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PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e23495Figure 7. The suppressive effect of BBR on the transcription of artificial plasmids. A (I) and A (II) signify the type of artificial plasmid model
used in this study. (B), (C), (D), (E), and (F) represent the effect of BBR on CMV-GFP, PPARc-GFP, IgG-GFP, CMV-RFP, and TPH2-RFP plasmids,
respectively. (G) illustrates the suppressive effect of BBR on the expression of these five plasmids 1 hour after drug administration. Data is the ratio of
the target gene in the BBR group to the same target gene in the BBR-free group at the same time-point (control group) * p,0.05, ** p,0.01 vs the
corresponding control indicated above. Data were presented as mean 6 S.D, from three independent experiments (n=3).
doi:10.1371/journal.pone.0023495.g007
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rejected by this system, data from this study illustrates that the
distribution of BBR in the nucleus can suppress gene transcription
without the presence of the cytoplasm.
The TATA box is a cis-regulatory element involved in the
process of gene transcription and can associate with TBP, allowing
the RNA polymerase II to unwind the DNA while recruiting other
transcriptional factors and subunits to form the transcriptional
complex to ultimately initiate transcription [25]. Due to the
disruptive effect of berberine on the interaction between TBP and
the TATA box, which was demonstrated by EMSA in vitro and
ChIP in living cells, there are at least two facts that can be
concluded: 1) the interaction between TBP and the TATA box is
one target of BBR in living cells, and 2) due of the fact that more
than 23.85% of eukaryotic promoters contain the TATA box
sequence [26], the suppressive effect of BBR on gene transcription
has no single-gene-specificity. Considering the architecture of the
minor groove of DNA for TBP binding to the TATA box [27], the
competitive obstruction of the TBP binding site by the non-
covalent, stereospecific insertion of BBR into the minor groove of
DNA is inferred as the mechanism for the suppressive effect of
BBR on gene transcription. Furthermore, because of the sub-
stantial possibility that the spatial conformational change of DNA
induced by a DNA intercalator may affect DNA-protein inter-
actions [28], the BBR-induced spatial conformational change of
DNA may also be a basis for the obstruction of binding between
TBP and the TATA box.
Taking everything together, this is the first report to describe a
general and universal effect of BBR on living biological systems in
detail: from the specific chemical features to the biological
functional level. The detection of the DNA binding character
with BBR and the suppressive effect on the association between
TBP and TATA box by BBR suggests that the non-specific
suppressive effect on gene transcription by BBR is a direct result of
its chemical features. Because the concentration of BBR in a living
cell’s nucleus could exceed 2.69 mmol at 2 hours following drug
Figure 8. The association of BBR with DNA can suppress the interaction between TBP and the TATA box. (A) represents the suppressive
effect of BBR on gene transcription in a cell-free system, where actinomycin D (AD) was used as the positive control drug because of its well-known
transcription inhibitory activity. (B) represents the suppressive effect of BBR on the association between TBP and the TATA box. B (I) is an image taken
via EMSA, and B (II) represents the effect of BBR on the binding of TBP to TATA box, (y=11.4686, ln-(x)+.60.55,R
2=0.9344, n=3. (C) represents the
time-dependent suppressive effect of BBR (2.69 mmol) on the interaction between TBP and the TATA box in live cells observed using ChIP. C (I) is one
of the images taken from a Western blot representing TBP, and C (II) displays the statistical results of brightness of TBP in Western blot images from
three independent experiments. C (III) and C (IV) depict the quantitative analysis of the TATA box-containing DNA fragment in the CMV promoter and
PPARc promoter bound by TBP from four independent experiments, the data of which was represented as the ratio of the content of DNA fragments
in BBR groups to the content in BBR-free groups at the same time-point (control group), input of each sample was used as inner reference. * P,0.05,
** p,0.01 vs the corresponding control indicated above. Data were presented as mean 6 S.D, from three independent experiments (n=3).
doi:10.1371/journal.pone.0023495.g008
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cell-free system can complement each other and support the
integrity of the entire study. Due to the definite association
between BBR and TATA box in living cells suffering from BBR
treatment, we believe that the non-specific suppressive effect on
gene transcription is one of the fundamental mechanisms
employed in the numerous pharmacological functions of BBR
that are exhibited in living systems. For instance, the suppression
of the PPARc promoter by BBR, which was discovered in this
study, is in good agreement with a previous report [29] describing
the possible mechanism of BBR inhibiting 3T3-L1 adipocyte
differentiation.
In contrast to our hypothesis, however, not all genes are down-
regulated after cell suffering from BBR treatment in previous
studies, including pgp-170 in human hepatoma cell lines [30], gata-
3 and gata-2 in 3T3L1 cell lines [31], insR in type 2 diabetes animal
models [32], wee1 in leukemia cells [33], and ldlr in hepatic cells
[34], etc. All of the promoters in these genes lack the canonical
TATA box sequence. However, coupled with the suppressive
effect of BBR on the TATA box-independent IgG promoter that
was discovered in this study, the possibility that BBR suppresses
TATA box-independent genes cannot be excluded because no
evidence has been made available to demonstrate that these
TATA box-independent genes are up-regulated through their
direct interaction with BBR. Therefore, the current theory
concerning BBR’s effect on TATA box-independent genes still
remains to be settled. Moreover, the mechanism involved in the
various drug responses by different genes is an interesting field that
requires much further work to completely study and understand.
Lastly, we would like to inquire what the role of such a simple and
definite function might be in generating an array of complex
pharmacological activities in a biological system. This would be
due to the complicated functional and structural features of the
biological system. We believe that this work can shed new light on
the pharmacological mechanisms of chemicals within living cells,
such as berberine, regarding the implementation of numerous
activities based on few specific targets.
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